Recently, the Centers for Medicare and Medicaid Services (CMS) announced the list of the first ten drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act (IRA), signed into law by President Biden in 2022. Under the Act, Medicare can directly negotiate the prices of certain high expenditure, single source drugs …